Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Battle Continues Over Compounded GLP-1s
The US Food and Drug Administration (FDA) has notified compounding pharmacies that the agency — at least temporarily — won’t take action against them for creating copies of the dual glucagon-dependent insulinotropic polypeptide/glucagon-like peptide 1 (GLP-1) drug tirzepatide (Eli Lilly…
English